Analysis of HIV-1 pol sequences using Bayesian networks: Implications for drug resistance

Bioinformatics

Volumn 22, Issue 24, 2006, Pages 2975-2979

  Deforche, Koen ^a   Silander, T ^b   Camacho, R ^c   Grossman, Z ^d   Soares, M A ^e   Van Laethem, K ^a   Kantor, R ^f   Moreau, Y ^g   Vandamme, A M ^g  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b HELSINKI INSTITUTE FOR INFORMATION TECHNOLOGY   (Finland)

^c HOSPITAL EGAS MONIZ   (Portugal)

^d MINISTRY OF HEALTH   (Israel)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f BROWN UNIVERSITY   (United States)

^g UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

NELFINAVIR; PROTEINASE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BAYES THEOREM; DRUG EXPOSURE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROBABILITY; SEQUENCE ANALYSIS; VIRUS MUTATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33845353741     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/btl508     Document Type: Article

References (20)

1. Abecasis,A.B. et al. (2005) Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G. AIDS, 19, 1799-1806.
2. Beerenwinkel,N. et al. (2004) Learning multiple evolutionary pathways from cross-sectional data. In RECOMB, ACM Press, pp. 36-44.
3. Beerenwinkel,N. et al. (2005) Estimating evolutionary pathways and the genetic barrier to drug resistance. J. Infect. Dis., 191, 1953-1960.
4. de Oliveira,T. et al. (2005) An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics, 21, 3797-3800.
5. Friedman,N., Goldszmidt,M. and Wyner,A.J. (1999) Data analysis with Bayesian networks: A bootstrap approach. In Proceedings of UAI-99 (Proceedings of the Fifteenth Conference on Uncertainty in Artificial Intelligence), Stockholm, Sweden, July 30-August 1, 1999, Morgan Kaufmann, pp. 206-215.
6. Gonzalez,L.M.F. et al. (2004) Impact of nelfinavir resistance mutations on in vitro phenotype, fitness, and replication capacity of human immunodeficiency virus type 1 with subtype B and C proteases. Antimicrob. Agents Chemother., 48, 3552-3555.
7. Grossman,Z. et al. (2004) Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir. Antimicrob. Agents Chemother., 48, 2159-2165.
8. Heckerman,D. (1999) A tutorial on learning with Bayesian networks. In Learning in graphical models, MIT Press, ISBN: 0-262-60032-3, pp, 301-354.
9. Kantor,R. and Katzenstein,D. (2004) Drug resistance in non-subtype B HIV-1. J. Clin. Virol., 29, 152-159.
10. Kantor,R. et al. (2001) Human immunodeficiency virus reverse transcriptase and protease sequence database: An expanded data model integrating natural language and sequence analysis programs. Nucleic Acids Res., 29, 296-269.
11. Kantor,R. et al. (2005) Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration. PLoS Med., 2, e112.
12. Klingler,T.M. and Brutlag,D.L. (1994) Discovering structural correlations in α-helices. Protein Sci., 3, 1847-1857.
13. Myllymäki, P. et al. (2002) B-Course: A web-based tutorial for Bayesian and caausal data analysis. Int. J. Art Intell. Tools, 11, 396-387.
14. Pearl,J. (1998) Graphical models for probabilistic and causal reasoning. In Gabbay,D.M. and Smets,P. (eds), Handbook of Defeasible Reasoning and Uncertainty Management Systems, Volume 1: Quantified Representation of Uncertainty and Imprecision. Kluwer Academic Publishers, Dordrecht, pp. 367-389.
15. Shafer,R.W. (2002) Genotypic testing for human immunodeficiency virus type 1 drug resistance. Clin. Microbiol. Rev., 15, 247-277.
16. Sing,T. et al. (2005) Characterization of novel HIV drug resistance mutations using clustering, multidimensional scaling and SVM-based feature ranking. In Jorge,A., Torgo,L., Brazdil,P., Camacho,R. and Gama,J. (eds), Knowledge Discovery in Databases: PKDD 2005. Springer, New York. ISBN: 3-540-29244-6.
17. Vandamme,A.-M. and De Clercq,E. (2001) Antiviral Therapy. ASM Press, Washington, US, ch.12, pp. 243-277.
18. Van Laethem,K. et al. (2002) A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1 infected patients. Antivir. Ther., 7, 1359-6535.
19. Wang,K. et al. (2004) Simple linear model provides highly accurate genotypic predictions of HIV-1 drug resistance. Antivir. Ther., 9, 343-352.
20. Wu,T.D. et al. (2003) Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments. J. Virol., 77, 4836-4847.